Gelonghui, April 8 | According to the latest equity disclosure data of the Stock Exchange, from April 2 to April 3, 2024, Changmao Biotech (00954.HK) was granted a total increase of 1.8 million shares by executive director Rui Xinsheng (Chairman) at an average price of HK$0.3796-0.38 per share on the market, involving about HK$750,000.

After increasing its holdings, Rui Xinsheng's latest shareholding was 9.34 million shares, and the shareholding ratio increased from 4.01% to 5.08%.